(Q50588724)
Statements
1 reference
A phase-I study of the safety, pharmacokinetics, and antiviral activity of combination didanosine and ribavirin in patients with HIV-1 disease. AIDS Clinical Trials Group 231 Protocol Team. (English)
1 reference
Japour AJ
1 reference
Lertora JJ
1 reference
Meehan PM
1 reference
Erice A
1 reference
Connor JD
1 reference
Griffith BP
1 reference
Clax PA
1 reference
Holden-Wiltse J
1 reference
Hussey S
1 reference
Walesky M
1 reference
Cooney E
1 reference
Pollard R
1 reference
Timpone J
1 reference
McLaren C
1 reference
Johanneson N
1 reference
Wood K
1 reference
Booth D
1 reference
Bassiakos Y
1 reference
Crumpacker CS
1 reference
1 November 1996
1 reference
13
1 reference
3
1 reference
235-246
1 reference
Identifiers
1 reference